Related Experiment Video
Updated: Feb 28, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives
Paloma Martín-Sanz1, Marta Casado1, Lisardo Boscá1
1Paloma Martín-Sanz, Lisardo Boscá, Department of Metabolism and Cell Signaling, Institute of Biomedical Research Alberto Sols, Madrid 28029, Spain.
Cyclooxygenase enzymes are key in producing prostaglandins and thromboxanes, impacting liver disease progression. Inhibitors and analogues offer therapeutic potential for metabolic and lipid disorders, fibrosis, and cancer.
Area of Science:
- Biochemistry
- Hepatology
- Pharmacology
Background:
- Prostaglandin and thromboxane biosynthesis is crucial in liver disease management.
- Cyclooxygenase enzymes initiate the production of these lipid mediators.
- Therapeutic agents targeting these pathways are established.
More Related Videos
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Related Concept Videos
Peroxisomes
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Drug Metabolism: Phase I Reactions
Mutagenicity and Carcinogenicity
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...